NQC, Nephros Pursuing Artificial Kidney Through Separate R&D Efforts
This article was originally published in The Gray Sheet
Executive Summary
National Quality Care will file an investigational device exemption within the next few months for a wearable artificial kidney device, the firm says
You may also be interested in...
Gambro Settles Medicare Billing Suit, Signs Corporate Integrity Agreement
Gambro Healthcare US will record a second quarter charge of $355 mil. to cover a definitive settlement agreement with the U.S. Department of Justice, expected to be completed by December
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.